☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Jacobio Pharma
Jacobio and Allist Pharmaceuticals Partner to Develop Glecirasib and JAB-3312 Across China
September 2, 2024
Jacobio Pharma Reports Data from the P-II Study of Glecirasib for Treating Non-Small Cell Lung Cancer
May 1, 2024
Jacobio Pharma’s Glecirasib Receives the NMPA’s Breakthrough Therapy Designation for the Treatment of Pancreatic Cancer
August 8, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.